DDW

<!-- Name:DistributionId Value:8753236 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4500 -->…

Physician’s Briefing Staff TUESDAY, May 31, 2022 (HealthDay News) -- A novel smartphone application can accurately determine Bristol Stool Scale (BSS) and other visual stool characteristics, according…

Physician’s Briefing Staff THURSDAY, May 26, 2022 (HealthDay News) -- Baseline cannabinoid use is associated with higher sedation use during endoscopy with endoscopist-directed conscious sedation,…

Newton, MA, May 26, 2022 (GLOBE NEWSWIRE) -- PuraStat®, a hemostatic agent made by 3-D Matrix Medical Technology, a leading global peptide solutions company, was prominently featured in several key presentations from key opinion leaders…

Results from an investigational Phase 3 PHALCON-EE trial demonstrating superior healing at week 2 in patients with LA Grade C/D (moderate-to-severe) erosive esophagitis and superior maintenance of healing at week 24 in all patients with…

SOUTH SAN FRANCISCO, Calif., May 24, 2022 (GLOBE NEWSWIRE) -- Surrozen, Inc. (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration, today announced the…

Physician’s Briefing Staff FRIDAY, May 13, 2022 (HealthDay News) -- Use of antibiotics, regardless of class, is associated with an increased risk of older-onset inflammatory bowel disease (IBD),…

Physician’s Briefing Staff FRIDAY, May 13, 2022 (HealthDay News) -- In the year prior to pancreatic ductal adenocarcinoma (PDAC) diagnosis, patients present with gallstone disease six times more often…

Physician’s Briefing Staff FRIDAY, May 13, 2022 (HealthDay News) -- While the prevalence of Barrett esophagus (BE) and esophageal cancer (EC) appears to have plateaued in the elderly, it is increasing…

The SEAVUE study is the first head-to-head trial that compares the safety and efficacy of prescription biologics in the treatment of Crohn's disease, and…